Pacific Biosciences of CaliforniaPACB
那斯達克 · USD
1.33
-0.05
(-3.62%)
收盤 08/02 03:59 (UTC+8)
盤後
1.32
1.32
(-0.75%)
08/02 03:59 (UTC+8)
Pacific Biosciences of CaliforniaPACB
1.33
-0.05
(-3.62%)
財務數據
損益表
- 0.27
- 0.39
- 0.48
- 0.56
- 0.58
- 0.39
- 0.36
- 0.40
- 0.39
- 0.37
- -15.34
- 42.21
- 22.30
- 17.06
- 4.79
- -33.50
- -7.21
- 10.98
- -1.86
- -5.28
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 37,153 | 39,224 | 39,967 | 36,013 | 38,810 | 58,357 | 55,691 | 47,573 | 38,900 | 27,353 |
營業成本 | 38,524 | 29,166 | 29,963 | 30,075 | 27,528 | 48,786 | 37,789 | 32,027 | 29,139 | 22,213 |
營業毛利 | -1,371 | 10,058 | 10,004 | 5,938 | 11,282 | 9,571 | 17,902 | 15,546 | 9,761 | 5,140 |
營業費用 | 427,563 | 163,086 | 74,081 | 181,784 | 92,644 | 97,119 | 100,394 | 88,721 | 101,013 | 92,224 |
研發費用 | 29,053 | 27,466 | 25,516 | 38,485 | 43,455 | 44,544 | 47,514 | 46,173 | 48,939 | 42,623 |
推銷及管理費用 | 21,468 | 39,691 | 44,916 | 45,877 | 43,683 | 47,096 | 43,160 | 42,548 | 52,074 | 49,601 |
非經常性項目費用 | 15,000 | 91,300 | - | 93,200 | - | 63 | 8,979 | - | - | - |
其他營業費用 | 362,042 | 4,629 | 3,649 | 4,222 | 5,506 | 5,416 | 741 | - | - | - |
營業利益 | -428,934 | -153,028 | -64,077 | -175,846 | -81,362 | -87,548 | -82,492 | -73,175 | -91,252 | -87,084 |
其他收入及費用 | 4,294 | 158,472 | 6,890 | 6,069 | 6,759 | 8,383 | 8,505 | 6,896 | 6,867 | 6,348 |
利息費用 | 1,737 | 2,757 | 3,538 | 3,542 | 3,575 | 3,571 | 3,588 | 3,554 | 3,630 | 4,110 |
稅前純益 | -426,377 | 2,687 | -60,725 | -173,319 | -78,178 | -82,736 | -77,575 | -69,833 | -88,015 | -84,384 |
所得稅 | -302 | 316 | - | - | - | -718 | -10,706 | - | - | - |
稅後純益 | -426,075 | 2,371 | -60,725 | -173,319 | -78,178 | -82,018 | -66,869 | -69,833 | -88,015 | -84,384 |
基本每股稅後盈餘(元) | -1.44 | 0.01 | -0.22 | -0.64 | -0.29 | -0.31 | -0.26 | -0.28 | -0.36 | -0.37 |
稀釋每股稅後盈餘(元) | -1.44 | -0.44 | -0.22 | -0.64 | -0.29 | -0.31 | -0.26 | -0.28 | -0.36 | -0.37 |
基本平均股數(千股) | 296858.00 | 282999.00 | 272915.00 | 272385.00 | 296858.00 | 267121.00 | 255001.00 | 250070.00 | 242032.00 | 226241.00 |
稀釋平均股數(千股) | 296858.00 | 306892.00 | 272915.00 | 272385.00 | 296858.00 | 267121.00 | 255001.00 | 250070.00 | 242032.00 | 226241.00 |
還原基本每股稅後盈餘(元) | -1.44 | 0.01 | -0.22 | -0.64 | -0.29 | -0.31 | -0.26 | -0.28 | -0.36 | -0.37 |
還原稀釋每股稅後盈餘(元) | -1.44 | -0.44 | -0.22 | -0.64 | -0.29 | -0.31 | -0.26 | -0.28 | -0.36 | -0.37 |
還原基本平均股數(千股) | 296,858 | 282,999 | 272,915 | 272,385 | 296,858 | 267,121 | 255,001 | 250,070 | 242,032 | 226,241 |
還原稀釋平均股數(千股) | 296,858 | 306,892 | 272,915 | 272,385 | 296,858 | 267,121 | 255,001 | 250,070 | 242,032 | 226,241 |
EBITDA(千元) | -53,567 | 14,012 | -44,179 | -159,029 | -66,620 | -70,218 | -72,507 | -65,049 | -81,862 | -76,403 |